Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2353–2376 of 8,279 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Meningitis, Meningococcal
Interventions: rLP2086 vaccine, control; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 10 Years to 25 Years
Enrollment: 5,715 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 39
States / cities: Huntsville, Alabama • Chandler, Arizona • Tempe, Arizona + 28 more

Conditions: Sleep, Postpartum Depression, Pregnancy Related, Insomnia, Sleep Deprivation, Sleep Hygiene, Sleep Disturbance
Interventions: Education about behavioral strategies to improve sleep; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Bacterial Conjunctivitis
Interventions: Besivance, Gatifloxacin; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 1 Day to 31 Days
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Oncology, Quality of Life
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 15 Years to 39 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 3
States / cities: Chicago, Illinois • Winston-Salem, North Carolina

Conditions: Pulmonary Embolism, Deep Vein Thrombosis, Minor Head Injury, Chest Pain, Neck Trauma
Interventions: Clinical Decision Rule Alerts; Other
Lead sponsor: University of Utah; Other
Eligibility: 16 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Physical Disability
Interventions: EnhanceWellness for Disability (EW-D), Wellness Education; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 45 Years to 64 Years
Enrollment: 516 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Bacterial Infections
Interventions: Dalbavancin; Drug
Lead sponsor: AbbVie; Industry
Eligibility: Up to 28 Days
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 5
States / cities: San Diego, California • Louisville, Kentucky • Kansas City, Missouri + 1 more

Conditions: People With Identified Painful Trigger Points (Tp) Within the Soleus and Gastrocnemius Muscles Complex, Healthy Subjects or Volunteers
Interventions: Dry needling with electrical stimulation, Dry needling, Electrical stimulation, Sham; Procedure
Lead sponsor: University of Rhode Island; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Kingston, Rhode Island

Conditions: Feeding Behavior
Interventions: Education; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 1 Week to 12 Months
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 40 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Influenza
Interventions: Pumarix™, Pandemrix ™; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 780 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 7
States / cities: Huntsville, Alabama • Anaheim, California • Miami, Florida + 4 more

Conditions: Cognitively Healthy People, Alzheimer Disease
Interventions: GENUS, Tactile GENUS; Device
Lead sponsor: Massachusetts Institute of Technology; Other
Eligibility: 18 Years to 100 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Photodamage of the Face, Anti Aging
Interventions: MASK LED, LED MASK AND COSMETIC FORMULA; Device · Combination Product
Lead sponsor: L'Oreal; Industry
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Patent Ductus Arteriosus After Premature Birth
Interventions: Ibuprofen; Drug
Lead sponsor: IWK Health Centre; Other
Eligibility: Up to 72 Hours
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Orange, California • San Diego, California • Oklahoma City, Oklahoma

Conditions: Stroke
Interventions: Aerobic Exercise, Exergame Training; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Head Lice
Interventions: LICEMD, Standard Head lice product; Drug
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 3 Years to 12 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Psoriasis
Interventions: Apremilast; Drug
Lead sponsor: Amgen; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 6
States / cities: San Diego, California • Atlanta, Georgia • Chicago, Illinois + 3 more

Conditions: Myocardial Infarction
Interventions: eptifibitide; Drug
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Age-Related Macular Degeneration (AMD)
Interventions: PAN-90806 Ophthalmic Solution, Lucentis; Drug
Lead sponsor: PanOptica, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 22
States / cities: Colorado Springs, Colorado • Winter Haven, Florida • Shawnee Mission, Kansas + 19 more

Conditions: Urinary Tract Infections, Infectious Diarrhea, Clostridium Difficile Infection, Gastrointestinal Disease, GastroIntestinal Bleeding
Interventions: TrueLoo™; Device
Lead sponsor: Toi Labs, Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 6
States / cities: Concord, California • Davis, California • Elk Grove, California + 2 more

Conditions: Age-Related Memory Disorders
Interventions: Transdermal nicotine patch, Placebo transdermal patch; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Durham, North Carolina • Burlington, Vermont

Conditions: Respiratory Syncytial Virus (RSV)
Interventions: Moderna RSV vaccine; Biological
Lead sponsor: Emory University; Other
Eligibility: 60 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Leukemia
Interventions: gemtuzumab ozogamicin, observation, Cytosine arabinoside, Daunomycin; Drug · Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years to 60 Years
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 255
States / cities: Anchorage, Alaska • Fort Smith, Arkansas • Little Rock, Arkansas + 161 more

Conditions: Influenza
Interventions: Baloxavir Marboxil, Oseltamivir; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 1 Year to 11 Years
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 27
States / cities: Birmingham, Alabama • Harrisburg, Arkansas • Jonesboro, Arkansas + 22 more

Search by objective public record fields.

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

The Dream Team: Testing Implementation of a Sleep Intervention for Perinatal Women Delivered by Direct Care Workers

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

Measuring Health Related Quality of Life in AYAs

Non-Interruptive Alerts for Improving Use of Clinical Decision Rules

A Community Wellness Program for Adults Living With Long-term Physical Disability

Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects

Evaluation of Feeding Practices in Latin American Infants at a Medical Home in Austin, Texas

Questionnaire Pre-Test Study

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)

Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage .

Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT

Aerobic Exercise in Patients With Stroke

Pediatric Head Lice Study Product Comparison

A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Eptifibatide and ST Segment Resolution Following Primary PCI

Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™

Nicotine Treatment of Mild Cognitive Impairment (MCI)

Systems Biological Analysis of Immune Responses to RSV Vaccine

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms